Abstract
CONGENERS of nitrogen monoxide (NO) are neuroprotective and neurodestructive1– 7. To address this apparent paradox, we considered the effects on neurons of compounds characterized by alternative redox states of NO: nitric oxide (NO.) and nitrosonium ion (NO+)8. Nitric oxide, generated from NO. donors or synthesized endogenously after NMDA (N-methyl-D-aspartate) receptor activation, can lead to neurotoxicity3,4. Here, we report that NO.-mediated neurotoxicity is engendered, at least in part, by reaction with superoxide anion (O.-2), apparently leading to formation of peroxynitrite (ONOO−), and not by NO. alone. In contrast, the neuroprotective effects of NO result from downregulation of NMDA-receptor activity by reaction with thiol group(s) of the receptor's redox modulatory site1. This reaction is not mediated by NO. itself, but occurs under conditions supporting S-nitrosylation of NMDA receptor thiol (reaction or transfer of NO+). Moreover, the redox versatility of NO allows for its interconversion from neuroprotective to neurotoxic species by a change in the ambient redox milieu. The details of this complex redox chemistry of NO may provide a mechanism for harnessing neuroprotective effects and avoiding neurotoxicity in the central nervous system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lei, S. Z. et al. Neuron 8, 1087–1099 (1992).
Manchester, K. S., Jensen, F. E., Warach, S. &. Lipton, S. A. Neurology 43, A365 (1993).
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 88, 6368–6371 (1991).
Dawson, T. M., Dawson, V. L. & Snyder, S. H. Ann. Neurol. 32, 297–311 (1992).
Nowicki, J. P., Duval, D., Poignet, H. & Scatton, B. Eur. J. Pharmac. 204, 339–340 (1991).
Moncada, C., Lekieffre, D., Arvin, B. & Meldrum, B. Neuroreport 3, 530–532 (1992).
Wallis, R. A., Panizzon, K. & Wasterlain, C. G. Neuroreport 3, 645–648 (1992).
Stamier, J. S., Singel, D. J. & Loscalzo, J. Science 258, 1898–1902 (1992).
Hogg, N., Darley-Usmar, V. M., Wilson, M. T. & Moncada, S. Biochem. J. 281, 419–424 (19923.
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. & Freeman, B. A. Proc. natn. Acad. Sci. U.S.A. 87, 1620–1624 (1990).
Radi, R., Beckman, J. S., Bush, K. M. & Freeman, B. A. J. biol. Chem. 266, 4244–4250 (1991).
Radi, R., Beckman, J. S., Bush, K. M. & Freeman, B. A. Arch. Biochem. Biophys. 288, 481–487 (1991).
Koppenol, W. H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H. & Beckman, J. S. Chem. Res. Toxicol. 5, 834–842 (1992).
Feelisch, M., Ostrowski, J. & Noack, E. J. cardiovasc. Pharmac. 14 (suppl. 11), S13–S22 (1989).
Ignarro, L. J. Hypertension 16, 477–483 (1990).
Ischiropoulos, H. et al. Arch. Biochem. Biophys. 298, 431–437 (1992).
Oury, T. D., Ho, Y.-S. Piantadosi, C. A. & Crapo, J. D. Proc. natn. Acad. Sci. U.S.A. 89, 9715–9719 (1992).
Bates, J. N., Baker, M. T., Guerra, R. Jr & Harrison, D. G. Biochem. Pharmac. 42 (suppl.), S157–S165 (1991).
Marks, G. S., McLaughlin, B. E., Nakatsu, K. & Brien, J. F. Can. J. Physiol. Pharmac. 70, 308–311 (1992).
Ignarro, L. J. et al. J. Pharmac. exp. Ther. 218, 739–749 (1981).
Noack, E. & Feelisch, M. Basic Res. Cardiol. 86 (suppl. 2), 37–50 (1991).
Olney, J. W., Zorumski, C., Price, M. T. & Labryuere, J. Science 248, 596–599 (1990).
Zumft, W. G. & Frunzke, K. Biochim. biophys. Acta 681, 459–468 (1982).
Hoyt, K. R., Tang, L.-H., Aizenman, E. & Reynolds, I. J. Brain Res. 592, 310–316 (1992).
Pryor, W. A., Church, D. F., Govinden, C. K. & Crank, G. J. org. Chem. 47, 156–159 (1982).
Feelisch, M. J. cardiovasc. Pharmac. 17 (suppl. 3), S25–S33 (1991).
Sucher, N. J. & Lipton, S. A. J. Neurosci. Res. 30, 582–591 (1991).
Choi, D. W. Neuron 1, 623–634 (1988).
Meldrum, B. & Garthwaite, J. Trends pharmacol. Sci. 11, 379–387 (1990).
Lipton, S. A. Trends Neurosci. 15, 75–79 (1992).
Bredt, D. S., Hwang, P. M. & Snyder, S. H. Nature 347, 768–770 (1990).
Liu, T. H., Beckman, J. S. Freeman, B. A., Hogan, E. L. & Hsu, C. Y. Am. J. Physiol. 256, 589–593 (1989).
Kinouchi, H. et al. Proc. natn. Acad. Sci. U.S.A. 89, 11158–11162 (1991).
Stamler, J. S. et al. Proc. natn. Acad. Sci. U.S.A. 89, 444–448 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipton, S., Choi, YB., Pan, ZH. et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626–632 (1993). https://doi.org/10.1038/364626a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/364626a0
This article is cited by
-
Cardiovascular adverse effects and mechanistic insights of arsenic exposure: a review
Environmental Chemistry Letters (2024)
-
Resident Astrocytes can Limit Injury to Developing Hippocampal Neurons upon THC Exposure
Neurochemical Research (2023)
-
Study of disorders in regulatory spatiotemporal neurodynamics of calcium and nitric oxide
Cognitive Neurodynamics (2023)
-
Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis
Nature Communications (2023)
-
S-Nitrosylation of cathepsin B affects autophagic flux and accumulation of protein aggregates in neurodegenerative disorders
Cell Death & Differentiation (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.